List view / Grid view
8 April 2016 | By Victoria White, Digital Content Producer
A new study shows that levels of eosinophils can help identify patients with COPD who may and may not benefit from the addition of ICS treatment...
8 April 2016 | By Victoria White, Digital Content Producer
The global treatment market for non-haematological cancers will almost double from $72.9 billion in 2014 to $140.8 billion in 2021, according to GBI Research...
8 April 2016 | By Victoria White, Digital Content Producer
Tesaro will receive an upfront payment of $35 million, and is eligible to receive additional milestone payments of up to $415 million...
8 April 2016 | By Victoria White
AstraZeneca and Lilly have announced that AMARANTH, a Phase II/III study of AZD3293 will continue into Phase III of the Phase II/III seamless trial...
7 April 2016 | By Victoria White, Digital Content Producer
Enrolment has started for two multinational clinical trials of an intravenously delivered investigational antibody for preventing HIV infection, VRC01...
7 April 2016 | By Victoria White, Digital Content Producer
Afatinib is approved for the treatment of patients whose disease has progressed on or after treatment with platinum-based chemotherapy...
7 April 2016 | By Victoria White
The approval includes the use of a new oral suspension formulation of Revolade designed for younger children who may not be able to swallow tablets...
7 April 2016 | By Perigord
Perigord has officially launched the latest release of their proprietary innovative software, GLAMS (Global Artwork Management System)...
6 April 2016 | By Victoria White
The EC has approved Opdivo (nivolumab) for locally advanced or metastatic NSCLC after prior chemotherapy and in advanced RCC after prior therapy...
6 April 2016 | By Black Swan Analysis
Research and Markets has announced the addition of the "Benign Prostatic Hypertrophy Forecast in 17 Major Markets 2016-2026" report to their offering...
Coulter Partners has placed Dr Neil Brewis as Chief Scientific Officer and Michael Davies as VP Protein Science at F-star, a leading biopharmaceutical company developing novel bispecific antibodies with a focus on immuno-oncology.
6 April 2016 | By Victoria White
The decision was driven by the actions announced by the US Department of Treasury, which the companies concluded qualified as an “Adverse Tax Law Change”...
6 April 2016 | By Victoria White
Cryoablation therapy, a targeted treatment using cold blasts, shows promise in improving the quality of life for patients suffering phantom limb pain...
6 April 2016 | By Victoria White
The confirmation of XR17 as a drug delivery system creates the potential for licensing opportunities in additional therapeutics outside of oncology...
6 April 2016 | By Victoria White, Digital Content Producer
With this approval, Celltrion's Inflectra becomes the first biosimilar monoclonal antibody (mAb) medication to receive approval in the US...
